Clinical Trial Update: Stellate Ganglion Block as Novel Treatment for Heart Failure Patients [Phase 2, Phase 3]

View source ↗

Summary

A clinical trial update discusses Stellate Ganglion Block as a treatment for heart failure in Phase 2 and Phase 3, with unclear status.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure

Drugs mentioned

• Stellate Ganglion Block

Snippet

Sponsor: Mina sobhi said fam | Conditions: Stellate Ganglion Block | Phase 2, Phase 3 | Status: UNKNOWN